Dr Harris (Deputy Chief Medical Officer, England) sent a minute to various officials discussing the need for the establishment of a blood safety body to consider the transmission of infections like NANBH, and noted that the EAGA was not the appropriate body since it was only concerned with AIDS. Read more about Dr Harris (Deputy Chief Medical Officer, England) sent a minute to various officials discussing the need for the establishment of a blood safety body to consider the transmission of infections like NANBH, and noted that the EAGA was not the appropriate body since it was only concerned with AIDS.
In an internal Department of Health minute from Dr David Kennedy to Dr Rejman, it was noted that the Chiron/Ortho test was under evaluation by the BTS and PHLS, and stated that another test, Fujiribo, was on the horizon. Read more about In an internal Department of Health minute from Dr David Kennedy to Dr Rejman, it was noted that the Chiron/Ortho test was under evaluation by the BTS and PHLS, and stated that another test, Fujiribo, was on the horizon.
Baroness Hooper wrote to Sir Robert McCrindle in relation to a letter he received from a constituent about Hepatitis C testing, and outlined the considerations that were examined in the decision on whether and when to introduce any new screening test. Read more about Baroness Hooper wrote to Sir Robert McCrindle in relation to a letter he received from a constituent about Hepatitis C testing, and outlined the considerations that were examined in the decision on whether and when to introduce any new screening test.
Dr Gunson suggested that the routine use of a test for blood donations in the UK should not commence before an FDA licensing procedure was effected. Read more about Dr Gunson suggested that the routine use of a test for blood donations in the UK should not commence before an FDA licensing procedure was effected.
Dr Gunson concluded that the evidence suggested that routine anti-HCV tests would reduce the incidence of transfusion-transmitted NANBH, and should be implemented. Read more about Dr Gunson concluded that the evidence suggested that routine anti-HCV tests would reduce the incidence of transfusion-transmitted NANBH, and should be implemented.
A Spanish study reported that approximately 60% of recipients of anti-HCV positive donor blood would go on to develop NANBH. Read more about A Spanish study reported that approximately 60% of recipients of anti-HCV positive donor blood would go on to develop NANBH.
The preliminary findings of the NBTS three-centre study showed that anti-HCV positivity indicated that a patient was suffering from non-A non-B Hepatitis, and that the test was detecting a viral marker associated with NANBH. The findings also included that, in general, 70-80% of patients suffering from treated (or severe) haemophilia were anti-HCV positive. Read more about The preliminary findings of the NBTS three-centre study showed that anti-HCV positivity indicated that a patient was suffering from non-A non-B Hepatitis, and that the test was detecting a viral marker associated with NANBH. The findings also included that, in general, 70-80% of patients suffering from treated (or severe) haemophilia were anti-HCV positive.
The preliminary findings of the NBTS three-centre study showed that 11 of 3,032 samples from Bristol (0.36%), 25 of 3,642 samples from Manchester (0.69%) and 25 of 3,010 samples from North London (0.83%) repeatedly tested positive for anti-HCV. Read more about The preliminary findings of the NBTS three-centre study showed that 11 of 3,032 samples from Bristol (0.36%), 25 of 3,642 samples from Manchester (0.69%) and 25 of 3,010 samples from North London (0.83%) repeatedly tested positive for anti-HCV.
Dr Mortimer of PHLS wrote to Dr Rejman noting that the case for Hepatitis C virus antibody testing was very strong, and that the UK should screen universally once the Ortho test and/or Abbott test was approved by the FDA in USA. He noted that they would otherwise be in a weak position if cases of transmission rose. Read more about Dr Mortimer of PHLS wrote to Dr Rejman noting that the case for Hepatitis C virus antibody testing was very strong, and that the UK should screen universally once the Ortho test and/or Abbott test was approved by the FDA in USA. He noted that they would otherwise be in a weak position if cases of transmission rose.
John Canavan circulated the first draft submission recommending the introduction of anti-HCV screening. Read more about John Canavan circulated the first draft submission recommending the introduction of anti-HCV screening.